Skip to main content

Neuroendocrine Tumour Centre

The Birmingham Neuroendocrine Tumour (NET) Centre is based at Queen Elizabeth Hospital Birmingham (QEHB).

It is a European Neuroendocrine Tumor Society certified Centre of Excellence, providing a specialist service to patients for over 30 years.

We deliver the latest cancer therapies to patients, including:

  • medical treatments for carcinoid syndrome
  • highly specialised cancer surgery
  • carcinoid heart disease surgery
  • nuclear medicine 'magic bullet' treatments such as Lutetium radionuclide therapy (called PRRT)
  • targeted chemotherapies such as everolimus and sunitinib
  • complex radiological interventions including radiofrequency ablation and trans-arterial embolisation
  • urology treatments
  • dietary advice
  • psychological and social support

We aim to provide a patient-focused service that is also convenient to access; all NET patients are managed according to individualised treatment plans.

Last reviewed: 14 May 2024